These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9151318)

  • 1. Expression studies of CLN3 protein.
    Kaczmarski W; Kida E; Lach A; Rubenstein R; Zhong N; Wisniewski KE
    Neuropediatrics; 1997 Feb; 28(1):33-6. PubMed ID: 9151318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein.
    Mitchison HM; Taschner PE; Kremmidiotis G; Callen DF; Doggett NA; Lerner TJ; Janes RB; Wallace BA; Munroe PB; O'Rawe AM; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):12-4. PubMed ID: 9151311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-species homology of the CLN3 gene.
    Taschner PE; de Vos N; Breuning MH
    Neuropediatrics; 1997 Feb; 28(1):18-20. PubMed ID: 9151313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesylation of Batten disease CLN3 protein.
    Pullarkat RK; Morris GN
    Neuropediatrics; 1997 Feb; 28(1):42-4. PubMed ID: 9151320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
    Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
    Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
    Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro.
    Kida E; Kaczmarski W; Golabek AA; Kaczmarski A; Michalewski M; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):265-71. PubMed ID: 10191113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical localization of the Batten disease (CLN3) protein in retina.
    Katz ML; Gao CL; Prabhakaram M; Shibuya H; Liu PC; Johnson GS
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2375-86. PubMed ID: 9344361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue expression and subcellular localization of CLN3, the Batten disease protein.
    Margraf LR; Boriack RL; Routheut AA; Cuppen I; Alhilali L; Bennett CJ; Bennett MJ
    Mol Genet Metab; 1999 Apr; 66(4):283-9. PubMed ID: 10191116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
    Pearce DA
    J Neurosci Res; 2000 Jan; 59(1):19-23. PubMed ID: 10658181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression studies of CLN3 protein (battenin) in fusion with the green fluorescent protein in mammalian cells in vitro.
    Golabek AA; Kaczmarski W; Kida E; Kaczmarski A; Michalewski MP; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):277-82. PubMed ID: 10191115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular trafficking of the JNCL protein CLN3.
    Haskell RE; Derksen TA; Davidson BL
    Mol Genet Metab; 1999 Apr; 66(4):253-60. PubMed ID: 10191111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for phosphorylation of CLN3 protein associated with Batten disease.
    Michalewski MP; Kaczmarski W; Golabek AA; Kida E; Kaczmarski A; Wisniewski KE
    Biochem Biophys Res Commun; 1998 Dec; 253(2):458-62. PubMed ID: 9878558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of membrane association of CLN3 protein.
    Kaczmarski W; Wisniewski KE; Golabek A; Kaczmarski A; Kida E; Michalewski M
    Mol Genet Metab; 1999 Apr; 66(4):261-4. PubMed ID: 10191112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Batten disease with the yeast Saccharomyces cerevisiae.
    Pearce DA; Sherman F
    Mol Genet Metab; 1999 Apr; 66(4):314-9. PubMed ID: 10191120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a transactivation motif in the CLN3 protein.
    Leung KY; Greene ND; Munroe PB; Mole SE
    IUBMB Life; 2001 May; 51(5):295-8. PubMed ID: 11699874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and chromosomal mapping of a mouse homolog of the Batten disease gene CLN3.
    Lee RL; Johnson KR; Lerner TJ
    Genomics; 1996 Aug; 35(3):617-9. PubMed ID: 8812504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3.
    Mitchison HM; Munroe PB; O'Rawe AM; Taschner PE; de Vos N; Kremmidiotis G; Lensink I; Munk AC; D'Arigo KL; Anderson JW; Lerner TJ; Moyzis RK; Callen DF; Breuning MH; Doggett NA; Gardiner RM; Mole SE
    Genomics; 1997 Mar; 40(2):346-50. PubMed ID: 9119403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttranslational modification of CLN3 protein and its possible functional implication.
    Michalewski MP; Kaczmarski W; Golabek AA; Kida E; Kaczmarski A; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):272-6. PubMed ID: 10191114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splicing variants in sheep CLN3, the gene underlying juvenile neuronal ceroid lipofuscinosis.
    Oswald MJ; Palmer DN; Damak S
    Mol Genet Metab; 1999 Jun; 67(2):169-75. PubMed ID: 10356317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.